Stockreport

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum

Anbio Biotechnology - Class A Ordinary Shares  (NNNN) 
PDF FRANKFURT AM MAIN, Germany, March 17, 2026 (GLOBE NEWSWIRE) -- Anbio Biotechnology (NASDAQ: NNNN) ("Anbio" or the "Company"), a global diagnostic company in in-vitro d [Read more]